Výsledky vyhledávání - "John, Quiring"

Elektronická kniha

Greening Philosophy of Religion : Process, Ecology, and Ethics

Autor: Jea S. Oh, John Quiring

Greening Philosophy of Religion: Process, Ecology, and Ethics develops fruitful avenues for the theory and practice of greening philosophy of religion. Collected with a pluralistic conception of both philosophy and religion, the chapters in this volu

Zobrazit plný text záznamu

Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials

Autor: Adelaide A. Hebert, Ramanan Gopalan, David M. Pariser, Dee Anna Glaser, Janice Drew, John Quiring

Publikováno v: American Journal of Clinical Dermatology

Background Glycopyrronium tosylate (GT) is a topical anticholinergic approved in the USA for primary axillary hyperhidrosis in patients aged ≥ 9 years. GT was evaluated for primary axillary hyperhidrosis in replicate, randomized, double-blind, vehi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd8ec86862b062e1be01d285c7032a0d
https://doi.org/10.1007/s40257-018-0395-0

Zobrazit plný text záznamu

A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis

Autor: Dee Anna Glaser, Janice Drew, Alexander Nast, Adelaide A. Hebert, John Quiring, William Philip Werschler, Richard Mamelok, Lawrence Green, David M. Pariser

Publikováno v: American Journal of Clinical Dermatology

Background Glycopyrronium tosylate is a topical anticholinergic approved in the USA for primary axillary hyperhidrosis in patients aged ≥ 9 years (Qbrexza™ [glycopyrronium] cloth, 2.4%). Objective This 44-week open-label extension study assessed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6dd69fd24481a8bf70652369aa4a47d
https://pubmed.ncbi.nlm.nih.gov/31111409

Zobrazit plný text záznamu

Injectable DaxibotulinumtoxinA for the Treatment of Glabellar Lines: A Phase 2, Randomized, Dose-Ranging, Double-Blind, Multicenter Comparison With OnabotulinumtoxinA and Placebo

Autor: Arthur Swift, Jacob M. Waugh, Nathan Rosen, Andrei I. Metelitsa, Shannon Humphrey, Channy Muhn, John Quiring, Nowell Solish, Jean Carruthers, Roman G. Rubio, Alastair Carruthers, Vince Bertucci, Gill Shears

Publikováno v: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 43(11)

Injectable daxibotulinumtoxinA (RT002) is an investigational botulinum toxin Type A in clinical development. It is formulated with a proprietary peptide and offers the potential of a longer acting neurotoxin therapy.To compare the safety, efficacy, a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2631439f6d253b5ba66070f004e89a64
https://pubmed.ncbi.nlm.nih.gov/28614091

Zobrazit plný text záznamu

Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials

Autor: Alexander Nast, Dee Anna Glaser, William Philip Werschler, Adelaide A. Hebert, David M. Pariser, Janice Drew, John Quiring, Richard Mamelok, Lawrence Green

Publikováno v: Journal of the American Academy of Dermatology. 80:128-138.e2

Glycopyrronium tosylate (GT) is a topical anticholinergic developed for once-daily treatment of primary axillary hyperhidrosis.Assess the efficacy and safety of GT for primary axillary hyperhidrosis.ATMOS-1 and ATMOS-2 were replicate randomized, doub

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82a2069bc4fe53fefbe19689305d52f9
https://doi.org/10.1016/j.jaad.2018.07.002

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání